This medical device stock looks like a gift for patient investors
Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?
AbbVie (NYSE: ABBV), one of the world’s largest pharmaceutical companies, is usually considered a blue chip dividend stock…
Meta’s latest move in the AI talent war, plus Cramer’s 4 quick hits
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Apple’s China breakthrough provides another tailwind for its stock
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?
Quick Read Abbott (ABT) is down 23% year to date with insiders buying near $92; Pfizer (PFE) pairs…
Cramer: The money to AI stocks is a problem, and how it can be fixed
We do not have enough money coming into this market. The funds flow only to stocks tied to…
Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange. NYSE U.S. stock futures were little changed…
Abbott closing Exact Sciences acquisition next week | News
MADISON, Wis. — Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.…
2 Healthcare Stocks to Buy in a Bear Market
It might not seem like it, but the S&P 500 flirted with bear market territory earlier this year.…
Retirement is changing. Here’s why companies need to change, too
America’s workforce is on the verge of an unprecedented transformation. More Americans are turning 65 in 2025 than…